MeMed For Profit
The immune system is built to communicate. Our mission is to listen. We apply machine learning to translate the complex signaling of the immune system into simple, actionable diagnostic insights. MeMed’s machine learning-based diagnostics address key clinical and medical challenges in infectious diseases and inflammatory disorders. MeMed BV Bacterial and viral infections are often clinically indistinguishable
Investors
Connections from
Industry:
Clinical Data Management
Funding Status:
Late Stage Venture
Estimated Revenue:
$26 Million
Employee Number:
101-250
Founded Date:
2009-01-01
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
Biomarker panels
Headquarters:
Tirat Carmel, Hefa, Israel
Investor Type:
N/A